Vis enkel innførsel

dc.contributor.authorHetlevik, Øysteinen_US
dc.contributor.authorGarre-Fivelsdal, Gina Dorotheaen_US
dc.contributor.authorBjorvatn, Bjørnen_US
dc.contributor.authorHjørleifsson, Stefanen_US
dc.contributor.authorRuths, Sabineen_US
dc.date.accessioned2020-05-13T12:08:02Z
dc.date.available2020-05-13T12:08:02Z
dc.date.issued2019
dc.PublishedHetlevik, Garre-Fivelsdal, Bjorvatn, Hjørleifsson, Ruths. Patient-reported depression treatment and future treatment preferences: an observational study in general practice. Family Practice. 2019;36(6):771-777eng
dc.identifier.issn0263-2136
dc.identifier.issn1460-2229
dc.identifier.urihttps://hdl.handle.net/1956/22234
dc.description.abstractBackground: Depression is prevalent in general practice, but few studies have explored patient-reported depression care. Aim: To investigate patient-reported treatment received for depression and future treatment preferences among adult patients visiting their GP, and to evaluate the associations with sex, age and educational level. Design and Setting: A cross-sectional survey was conducted in general practices in Norway from 2016 to 2017. Methods: Altogether, 2335 consecutive patients (response rate, 89.2%) in the GPs’ waiting rooms answered a questionnaire about their received depression treatment and treatment preferences in case of future depression. Results: The study population (N = 2239) had a mean age of 48.6 ± 17.7 years (range 18–91), 60.1% were women. Of the 770 patients reporting to have received depression treatment, 39.1% were treated exclusively by their GP while 52.5% also were referred to a psychologist/psychiatrist. Older age was positively associated with medication and negatively associated with referrals to psychologist/psychiatrist. People with high education had lower odds for receiving medication (odds ratios [OR], 0.49; 95% confidence intervals [CI]: 0.30–0.80) compared to those with low education. If future depression, 81.6% of the respondents would discuss this with their GP, 60.9% would prefer talking therapy with their GP, 22.5% medication, and 52.9% referral to psychologist or psychiatrist. Conclusion: One-third of the patients attending their GPs had consulted with them at some time concerning depression the case of future depression, most patients preferred talking therapy with the GP. This finding warrants increased research focus on the GP’s role in depression care.en_US
dc.language.isoengeng
dc.publisherOxford University Presseng
dc.subjectAllmennmedisin / General Practiceeng
dc.subjectDepresjon / Depressioneng
dc.subjectPasienter / Patientseng
dc.subjectPreferanser / Preferenceseng
dc.subjectTerapi / Therapeuticseng
dc.titlePatient-reported depression treatment and future treatment preferences: an observational study in general practiceen_US
dc.typePeer reviewed
dc.typeJournal article
dc.date.updated2020-01-31T08:04:04Z
dc.description.versionacceptedVersionen_US
dc.rights.holderCopyright 2019 The Author(s). All rights reserved
dc.subject.hrcsMental helse: Helse- og sosialtjenesteforskning
dc.subject.hrcsMental Health : Health and Social Care Services Research
dc.identifier.doihttps://doi.org/10.1093/fampra/cmz026
dc.identifier.cristin1709069
dc.source.journalFamily Practice
dc.source.pagenumber771-777
dc.subject.nsiVDP::Medisinske fag: 700
dc.subject.nsiVDP::Midical sciences: 700
dc.identifier.citationFamily Practice. 2019;36(6):771-777
dc.source.volume36
dc.source.issue6


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel